Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 71 - 80 of 237

Wounds, Withdrawal, and Overdose: What to Expect from Xylazine Drug Supply Adulteration

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
Video

(PCL-5) PTSD Checklist for DSM5 (PDF - 65.4 KB)

20-item checklist for PTSD that can be used to track PTSD symptoms over time. This scoring template was posted by Oregon Health and Science University (OHSU).

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
Source
Brush Education
Year
Resource Type
PDF

Bringing Alcohol and Other Drug Research to Primary Care

This course trains providers on evidence-based treatment options for opioid use disorders. It offers 2 continuing medical educations credits.

Format
Web-Based Course
Audience
Medical Providers
Other Team Members
Behavioral Health Providers
Source
Baylor College of Medicine (BCM)
Year
Resource Type
Web Page

Food and Drug Administration Overdose Prevention Framework (PDF - 146 KB)

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.
Format
Toolkit
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Food and Drug Administration (FDA)
Year
Resource Type
PDF

Medications, Counseling, and Related Conditions

This web page displays information and resources about medication-assisted treatment (MAT) for substance use disorders, including most commonly used medicines and behavioral therapies.

Format
Web Page
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

Pregnant and Postpartum Women and Behavioral Health Integration

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
Agency of Healthcare Quality and Research (AHRQ) Integration Academy
Year
Resource Type
Web Page